This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Sep-Oct;11(5):383-4.

doi: 10.1097/00130404-200509000-00004.

Prostate implant therapy: iodine-125 versus palladium-103

Richard E Peschel¹

Affiliations

PMID: 16259868
DOI: 10.1097/00130404-200509000-00004

Comment

Prostate implant therapy: iodine-125 versus palladium-103

Richard E Peschel. Cancer J. 2005 Sep-Oct.

. 2005 Sep-Oct;11(5):383-4.

doi: 10.1097/00130404-200509000-00004.

Author

Richard E Peschel¹

Affiliation

¹ Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. richard.peschel@yale.edu

PMID: 16259868
DOI: 10.1097/00130404-200509000-00004

No abstract available

PubMed Disclaimer

Comment on

I-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trial.
Herstein A, Wallner K, Merrick G, Mitsuyama H, Armstrong J, True L, Cavanagh W, Butler W. Herstein A, et al. Cancer J. 2005 Sep-Oct;11(5):385-9. doi: 10.1097/00130404-200509000-00005. Cancer J. 2005. PMID: 16259869 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information